MX392144B - Compuestos tipo pederina y el uso de los mismos en el tratatamiento de cáncer. - Google Patents

Compuestos tipo pederina y el uso de los mismos en el tratatamiento de cáncer.

Info

Publication number
MX392144B
MX392144B MX2019010890A MX2019010890A MX392144B MX 392144 B MX392144 B MX 392144B MX 2019010890 A MX2019010890 A MX 2019010890A MX 2019010890 A MX2019010890 A MX 2019010890A MX 392144 B MX392144 B MX 392144B
Authority
MX
Mexico
Prior art keywords
sub
pederin
compounds
cancer treatment
type compounds
Prior art date
Application number
MX2019010890A
Other languages
English (en)
Spanish (es)
Other versions
MX2019010890A (es
Inventor
La Calle Verdú Fernando De
Hernández Librada María Cañedo
Sánchez María Del Carmen Schleissner
Ramos María Pilar Rodríguez
Girón Paz Zúñiga
Original Assignee
Pharma Mar Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharma Mar Sa filed Critical Pharma Mar Sa
Publication of MX2019010890A publication Critical patent/MX2019010890A/es
Publication of MX392144B publication Critical patent/MX392144B/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
    • C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/02—Oxygen as only ring hetero atoms
    • C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/07—Bacillus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/185—Escherichia
    • C12R2001/19—Escherichia coli
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/38—Pseudomonas
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/465—Streptomyces

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
MX2019010890A 2017-03-17 2018-03-16 Compuestos tipo pederina y el uso de los mismos en el tratatamiento de cáncer. MX392144B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17382140 2017-03-17
PCT/EP2018/056665 WO2018167270A1 (en) 2017-03-17 2018-03-16 Anticancer compounds

Publications (2)

Publication Number Publication Date
MX2019010890A MX2019010890A (es) 2019-12-19
MX392144B true MX392144B (es) 2025-03-21

Family

ID=58398130

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019010890A MX392144B (es) 2017-03-17 2018-03-16 Compuestos tipo pederina y el uso de los mismos en el tratatamiento de cáncer.
MX2021011385A MX2021011385A (es) 2017-03-17 2019-09-12 Compuestos antineoplasicos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2021011385A MX2021011385A (es) 2017-03-17 2019-09-12 Compuestos antineoplasicos.

Country Status (17)

Country Link
US (1) US20210317490A1 (https=)
EP (1) EP3596068A1 (https=)
JP (1) JP7209633B2 (https=)
KR (1) KR102547649B1 (https=)
CN (1) CN110650954B (https=)
AU (2) AU2018235140B2 (https=)
BR (1) BR112019019301A2 (https=)
CA (1) CA3056725A1 (https=)
CL (2) CL2019002661A1 (https=)
IL (2) IL292572A (https=)
MA (1) MA49880A (https=)
MX (2) MX392144B (https=)
MY (2) MY202630A (https=)
SG (1) SG11201908267XA (https=)
UA (1) UA126338C2 (https=)
WO (1) WO2018167270A1 (https=)
ZA (2) ZA201906518B (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12156523B2 (en) 2017-03-17 2024-12-03 Mmag Co., Ltd. Plant disease control agent
CN114615999B (zh) * 2019-09-05 2024-03-08 法马马有限公司 药物抗体偶联物
CN112661808B (zh) * 2020-12-23 2022-05-27 浙江大学 一种酯肽类化合物及其制备方法和应用
EP4326869A4 (en) * 2021-04-20 2025-12-10 Univ Of Louisville RECOMBINATING MICRO-NECK

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2040338T3 (es) 1987-04-29 1993-10-16 Harbor Branch Oceanographic Institution, Inc. Compuestos antitumorales y antiviricos de origen marino.
US4801606A (en) 1987-07-17 1989-01-31 Harbor Branch Oceanographic Institution Inc. Antiviral compositions
EP1448767B1 (en) 2001-11-22 2010-10-13 Rheinische Friedrich-Wilhelms-Universität Bonn Novel gene cluster of pederin biosynthesis genes
WO2013016120A1 (en) 2011-07-22 2013-01-31 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Pederin and psymberin agents

Also Published As

Publication number Publication date
KR20190129950A (ko) 2019-11-20
MX2019010890A (es) 2019-12-19
IL269353B (en) 2022-06-01
AU2018235140B2 (en) 2021-11-11
CL2019002661A1 (es) 2019-12-27
JP2020510065A (ja) 2020-04-02
CA3056725A1 (en) 2018-09-20
CN110650954B (zh) 2023-11-03
IL269353A (en) 2019-11-28
WO2018167270A1 (en) 2018-09-20
RU2019132808A3 (https=) 2021-10-04
AU2021277683A1 (en) 2021-12-23
JP7209633B2 (ja) 2023-01-20
IL292572A (en) 2022-06-01
CN110650954A (zh) 2020-01-03
US20210317490A1 (en) 2021-10-14
AU2018235140A1 (en) 2019-10-03
AU2021277683B2 (en) 2023-03-09
MX2021011385A (es) 2021-10-13
CL2021000117A1 (es) 2021-07-30
MA49880A (fr) 2020-06-24
MY202630A (en) 2024-05-10
EP3596068A1 (en) 2020-01-22
KR102547649B1 (ko) 2023-06-23
UA126338C2 (uk) 2022-09-21
MY195435A (en) 2023-01-20
RU2019132808A (ru) 2021-04-19
ZA201906518B (en) 2021-01-27
SG11201908267XA (en) 2019-10-30
BR112019019301A2 (pt) 2020-04-28
ZA202006147B (en) 2023-03-29

Similar Documents

Publication Publication Date Title
ZA202213527B (en) Methods of preparing growing polynucleotides using nucleotides with 3' aom blocking group
PH12019500706A1 (en) Cyclic dinucleotide compounds
JOP20190254A1 (ar) مركبات مضادة للأورام
MX2020012765A (es) Métodos y compuestos de ácido nucleico modificado con lípidos.
BR112018013808A2 (pt) dinucleotídeos cíclicos para o tratamento de condições associadas à atividade de sting, tal como câncer
ECSP20018487A (es) Activadores de piruvato quinasas para usar en el tratamiento de trastornos en la sangre
CL2018003323A1 (es) Piridinas sustituidas con heteroarilo y métodos de uso.
NZ607996A (en) Substituted nucleotide analogs
CR20180367A (es) Compuestos útiles como inhibidores de cinasa
CU20170094A7 (es) Derivados de 4h-pirrol[3,2-c]piridin-4-0na
MX392144B (es) Compuestos tipo pederina y el uso de los mismos en el tratatamiento de cáncer.
EA201791058A1 (ru) Морфолин- и 1,4-оксазепан-амиды в качестве агонистов соматостатинового рецептора подтипа 4 (sstr4)
MX2020005640A (es) Anticuerpos anti-liv1 humanizados para el tratamiento de cancer de mama.
CL2017001336A1 (es) Nuevos aminoácidos ester fosforamidatos 2' y/o 5', 3' deoxiadenosina derivativos como compuestos anticancerígenos
PH12016500643A1 (en) New octahydro - cyclobuta [1,2-c;3,4-c`] dipyrrol -2- yl
NZ727392A (en) Methods of preparing substituted nucleotide analogs
SA520411974B1 (ar) تركيبات بولي كربونات
EA201891808A1 (ru) Трис-амидные соединения и композиции, содержащие их
MX378408B (es) Eteraminas a base de 1,2-dialcoholes.
IN2015KN00569A (https=)
EA201891866A1 (ru) N,N-ДИМЕТИЛ-3-[[5-(3-МЕТИЛ-2-ОКСО-1-ТЕТРАГИДРОПИРАН-4-ИЛ-ИМИДАЗО[4,5-c]ХИНОЛИН-8-ИЛ)-2-ПИРИДИЛ]ОКСИ]ПРОПАН-1-АМИНОКСИД В КАЧЕСТВЕ МОДУЛЯТОРА АТМ-КИНАЗЫ (МУТАЦИИ АТАКСИИ-ТЕЛЕАНГИЭКТАЗИИ) ДЛЯ ЛЕЧЕНИЯ РАКА
WO2016014864A8 (en) Hydroxy-(r),(r)-2,2'-bismethylnaltrexones and uses thereof
ES2397885A1 (es) Derivados de colismicina.
RU2014130710A (ru) Стимулятор роста яровой пшеницы
UA126922U (uk) Поліетергуанідин з сульфогрупами як поверхнево-активна речовина